Skip to content

Erwin Dreesen

  • MSc, PharmD
  • Catholic University of Leuven
  • 5h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 81CitationsNumber of citations received by Erwin's publications. Updated daily.

Other IDs

Co-authors (39)

Publications (5)

  • Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab

    • Strik A
    • Dreesen E
    • Samaan M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics

    • Murias S
    • Magallares L
    • Albizuri F
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit from Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling

    • Passot C
    • Pouw M
    • Mulleman D
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Variability in golimumab exposure: A 'real-life' observational study in active ulcerative colitis

    • Detrez I
    • Dreesen E
    • Van Stappen T
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Neutralisation of Soluble Tumor Necrosis Factor

    • E. D
    N/AReaders
    N/ACitations
    Get full text

Education

Katholieke Universiteit Leuven